Citations

Showing 10 of 108104 citations.

CD3+ and CD8+ tumor-infiltrating lymphocyte (TIL) densities to prognostically stratify DNA mismatch repair-deficient (dMMR) colon cancer patients (pts): NCCTG N0147 (Alliance).
Yoon, Harry H. , Heying, Erica N., Murányi, Andrea , Ough, Faith , Djalilvand, Azita, Clements, June, Bowermaster, Rebecca, Shanmugam, Kandavel , Shi, Qian , Liu, Wenwei , Barnes, Michael, Alberts, Steven R. , Sinicrope, Frank A.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 3598-3598

10.1200/jco.2018.36.15_suppl.3598 Get It

Genome-wide association with survival in stage II-III colon cancer clinical trials (NCCTG N0147, Alliance for Clinical Trials in Oncology; NSABP C-08, NRG Oncology).
Banbury, Barbara L. , Allegra, Carmen J. , Peters, Ulrike , Nair, Suresh , Harrison, Tabitha A. , Goldberg, Richard M. , Lucas, Peter C. , Colangelo, Linda H., Atkins, James N., Harrison, Tabitha A , Lucas, Peter C , Penney, Kathryn , Shi, Qian , Alberts, Steven R. , Yothers, Greg , Sinicrope, Frank A. , Sun, Wei , Newcomb, Polly A. , Chan, Andrew T.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 3582-3582

10.1200/jco.2018.36.15_suppl.3582 Get It

Impact of MLH1, PMS2, MSH2, and MSH6 alterations on tumor mutation burden (TMB) and PD-L1 expression in 1,057 microsatellite instability-high (MSI-H) tumors.
Salem, Mohamed E. , Kim, Edward S. , Xiu, Joanne , Goldberg, Richard M. , Shields, Anthony F. , Seeber, Andreas , Hwang, Jimmy J., Philip, Philip Agop, Lenz, Heinz‐Josef , Puccini, Alberto , Grothey, Axel , Korn, Wolfgang Michael , Raghavan, Derek , Marshall, John L

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 3572-3572

10.1200/jco.2018.36.15_suppl.3572 Get It

Association of high baseline ferritin with tocilizumab administration for CRS in relapsed/refractory multiple myeloma patients treated with bb2121 anti-BCMA CAR T cells.
Munshi, Nikhil C. , Liedtke, Michaela , Madduri, Deepu , Turka, Ashley, Lam, Lyh Ping, Hege, Kristen , Campbell, Timothy , Massaro, Monica, Berdeja, Jesús G. , Lin, Yi , Kochenderfer, James N. , Raje, Noopur , Siegel, David S. , Rosenblatt, Jacalyn , Maus, Marcela V , Petrocca, Fabio , Jagannath, Sundar

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e15062-e15062

10.1200/jco.2018.36.15_suppl.e15062 Get It

SEA-CD40, a non-fucosylated CD40 agonist: Interim results from a phase 1 study in advanced solid tumors.
Curti, Brendan D. , Smith, David C. , Rixe, Olivier , Bajor, David L. , Gutierrez, Martin , Kuzel, Timothy M. , Amore, Benny , Grilley‐Olson, Juneko E. , Goel, Sanjay , Gajewski, Thomas Frank , Markovic, Svetomir N. , Mehta, Amitkumar , Guerrero, Abraham, Wang, Zejing , Coveler, Andrew L.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 3093-3093

10.1200/jco.2018.36.15_suppl.3093 Get It

Phase 1b multi-indication study of the antibody drug conjugate anetumab ravtansine in patients with mesothelin-expressing advanced or recurrent malignancies.
Adjei, Alex A. , Philip, Philip Agop, Mercadé, T. Macarulla, Walter, Annette O., Cupit, Lisa, Fields, Scott Z., Holynskyj, Ariadna, Bekaii‐Saab, Tanios , Berlin, Jordan D. , Liu, Rong

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS2607-TPS2607

10.1200/jco.2018.36.15_suppl.tps2607 Get It

Radiosurgery and immune checkpoint inhibition in the treatment of brain metastases: A meta-analysis of patient-level data.
Lehrer, Eric J. , Peterson, Jennifer , Brown, Paul D. , Sheehan, Jason P. , Quiñones‐Hinojosa, Alfredo , Zaorsky, Nicholas G. , Trifiletti, Daniel M.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e14009-e14009

10.1200/jco.2018.36.15_suppl.e14009 Get It

Impact of apolipoprotein E (APOE) genotype on neurocognitive function (NCF) in patients with brain metastasis (BM): An analysis of NRG Oncology’s RTOG 0614.
Deshmukh, Snehal, Brown, Paul D. , Grosshans, David R. , Cerhan, Jane H. , Khuntia, Deepak , Shi, Wenyin , Laack, Nadia N., Chen, Yuhchyau , Curtis, Amarinthia, Laba, Joanna, Mowat, Rex B., Thakrar, Anu, Pugh, Stephanie L. , Wefel, Jeffrey S. , Sulman, Erik P. , Mehta, Minesh P. , Mishra, Mark V. , Suh, John H. , Bruner, Deborah Watkins , Shi, Wenyin

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 2065-2065

10.1200/jco.2018.36.15_suppl.2065 Get It

Dianhydrogalactitol in bevacizumab-refractory GBM: Further analysis of a phase 1-2 trial.
Shih, Kent C. , Patel, Manish R. , Butowski, Nicholas , Kizilbash, Sani H. , Bacha, Jeffrey , Brown, Dennis , Schwartz, Richard S. , Kanekal, Sarath, Constant, John C.I., Burris, Howard A. , Kizilbash, Sani H , Falchook, Gerald Steven , Jones, Suzanne Fields

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 2061-2061

10.1200/jco.2018.36.15_suppl.2061 Get It

TGF-beta/AURKA pharmacologic targeting to halt stemness and TNBC progression.
D’Assoro, Antonino B.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e13127-e13127

10.1200/jco.2018.36.15_suppl.e13127 Get It